Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases.
Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases.
复制标题
DOI:
10.1002/ijc.23625
复制
发表时间:
2008-09-01
影响因子:
6.4
通讯作者:
Li, Yonghe
中科院分区:
文献类型:
--
作者:
Bu, Guojun;Lu, Wenyan;Liu, Chia-Chen;Selander, Katri;Yoneda, Toshiyuki;Hall, Christopher;Keller, Evan T.;Li, Yonghe
Most breast cancer metastases in bone form osteolytic lesions, but the mechanisms of tumor-induced bone resorption and destruction are not fully understood. Although it is well recognized that Wnt/β-catenin signaling is important for breast cancer tumorigenesis, the role of this pathway in breast cancer bone metastasis is unclear. Dickkopf1 (Dkk1) is a secreted Wnt/β-catenin antagonist. In the present study, we demonstrated that activation of Wnt/β-catenin signaling enhanced Dkk1 expression in breast cancer cells and that Dkk1 over-expression is a frequent event in breast cancer. We also found that human breast cancer cell lines that preferentially form osteolytic bone metastases exhibited increased levels of Wnt/β-catenin signaling and Dkk1 expression. Moreover, we showed that breast cancer cell-produced Dkk1 blocked Wnt3A-induced osteoblastic differentiation and osteoprotegerin (OPG) expression of osteoblast precursor C2C12 cells, and that these effects could be neutralized by a specific anti-Dkk1 antibody. In addition, we found that breast cancer cell conditioned media were able to blocked Wnt3A-induced NF-kappaB ligand reduction in C2C12 Cells. Finally, we demonstrated that conditioned media from breast cancer cells in which Dkk1 expression had been silenced via RNAi were unable to block Wnt3A-induced C2C12 osteoblastic differentiation and OPG expression. Taken together, these results suggest that breast cancer-produced Dkk1 may be an important mechanistic link between primary breast tumors and secondary osteolytic bone metastases.
登录
查看更多内容
影响因子:
6.2
作者:
Chung, GG;Zerkowski, MP;Rimm, DL
通讯作者:
Rimm, DL
影响因子:
11.2
作者:
Fisher, JL;Thomas-Mudge, RJ;Gillespie, MT
通讯作者:
Gillespie, MT
影响因子:
50.3
作者:
Kang, YB;Siegel, PM;Massagué, J
通讯作者:
Massagué, J
影响因子:
8
作者:
Gonzálex-Sancho, JM;Aguilera, O;Muñoz, A
通讯作者:
Muñoz, A
影响因子:
11.8
作者:
Day, TF;Guo, XZ;Yang, YZ
通讯作者:
Yang, YZ